» Articles » PMID: 19273598

The P53 Tumor Suppressor Causes Congenital Malformations in Rpl24-deficient Mice and Promotes Their Survival

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 2009 Mar 11
PMID 19273598
Citations 61
Authors
Affiliations
Soon will be listed here.
Abstract

Hypomorphic mutation in one allele of ribosomal protein l24 gene (Rpl24) is responsible for the Belly Spot and Tail (Bst) mouse, which suffers from defects of the eye, skeleton, and coat pigmentation. It has been hypothesized that these pathological manifestations result exclusively from faulty protein synthesis. We demonstrate here that upregulation of the p53 tumor suppressor during the restricted period of embryonic development significantly contributes to the Bst phenotype. However, in the absence of p53 a large majority of Rpl24(Bst/+) embryos die. We showed that p53 promotes survival of these mice via p21-dependent mechanism. Our results imply that activation of a p53-dependent checkpoint mechanism in response to various ribosomal protein deficiencies might also play a role in the pathogenesis of congenital malformations in humans.

Citing Articles

RPL24 as a potential prognostic biomarker for cervical cancer treated by Cisplatin and concurrent chemoradiotherapy.

Ming C, Bai X, Zhao L, Yu D, Wang X, Wu Y Front Oncol. 2023; 13:1131803.

PMID: 37920171 PMC: 10619668. DOI: 10.3389/fonc.2023.1131803.


All these screens that we've done: how functional genetic screens have informed our understanding of ribosome biogenesis.

Harold C Biosci Rep. 2023; 43(7).

PMID: 37335083 PMC: 10329186. DOI: 10.1042/BSR20230631.


Ribosomal protein mutations and cell competition: autonomous and nonautonomous effects on a stress response.

Kiparaki M, Baker N Genetics. 2023; 224(3).

PMID: 37267156 PMC: 10691752. DOI: 10.1093/genetics/iyad080.


Eukaryotic Elongation Factor 2 Kinase Activity Is Required for the Phenotypes of the Rpl24 Mouse.

Knight J, Proud C, Mallucci G, von der Haar T, Smales C, Willis A J Invest Dermatol. 2022; 142(12):3346-3348.e1.

PMID: 35850210 PMC: 9708116. DOI: 10.1016/j.jid.2022.06.019.


Cell autonomous and non-autonomous consequences of deviations in translation machinery on organism growth and the connecting signalling pathways.

Surya A, Sarinay-Cenik E Open Biol. 2022; 12(4):210308.

PMID: 35472285 PMC: 9042575. DOI: 10.1098/rsob.210308.


References
1.
Zhao L, Samuels T, Winckler S, Korgaonkar C, Tompkins V, Horne M . Cyclin G1 has growth inhibitory activity linked to the ARF-Mdm2-p53 and pRb tumor suppressor pathways. Mol Cancer Res. 2003; 1(3):195-206. View

2.
Komarov P, Komarova E, Kondratov R, Coon J, Chernov M, Gudkov A . A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science. 1999; 285(5434):1733-7. DOI: 10.1126/science.285.5434.1733. View

3.
Schmid P, Lorenz A, Hameister H, Montenarh M . Expression of p53 during mouse embryogenesis. Development. 1991; 113(3):857-65. DOI: 10.1242/dev.113.3.857. View

4.
Budde A, Grummt I . p53 represses ribosomal gene transcription. Oncogene. 1999; 18(4):1119-24. DOI: 10.1038/sj.onc.1202402. View

5.
Gazda H, Grabowska A, Merida-Long L, Latawiec E, Schneider H, Lipton J . Ribosomal protein S24 gene is mutated in Diamond-Blackfan anemia. Am J Hum Genet. 2006; 79(6):1110-8. PMC: 1698708. DOI: 10.1086/510020. View